Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Risk Factors for Death in Patients With Empyema and Active Malignancy.
Salahuddin M, Ost D, Hwang H, Jimenez C, Saltijeral S, Eapen G, Casal R, Sabath B, Lin J, Cerrillos E, Nevárez Tinoco T, Grosu H. Salahuddin M, et al. Among authors: hwang h. Cureus. 2023 Apr 13;15(4):e37545. doi: 10.7759/cureus.37545. eCollection 2023 Apr. Cureus. 2023. PMID: 37197128 Free PMC article.
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia.
Abou Dalle I, Ghorab A, Patel K, Wang X, Hwang H, Cortes J, Issa GC, Yalniz F, Sasaki K, Chihara D, Price A, Kadia T, Pemmaraju N, Daver N, DiNardo C, Ravandi F, Kantarjian HM, Borthakur G. Abou Dalle I, et al. Among authors: hwang h. Blood Cancer J. 2020 May 4;10(5):48. doi: 10.1038/s41408-020-0318-1. Blood Cancer J. 2020. PMID: 32366841 Free PMC article.
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML.
Short NJ, Rafei H, Daver N, Hwang H, Ning J, Jorgensen JL, Kadia TM, DiNardo CD, Wang SA, Jabbour E, Popat U, Oran B, Cortes J, Konopleva M, Yilmaz M, Issa GC, Kantarjian H, Ravandi F. Short NJ, et al. Among authors: hwang h. Blood Adv. 2020 Dec 22;4(24):6117-6126. doi: 10.1182/bloodadvances.2020002811. Blood Adv. 2020. PMID: 33351107 Free PMC article.
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia.
Short NJ, Montalban-Bravo G, Hwang H, Ning J, Franquiz MJ, Kanagal-Shamanna R, Patel KP, DiNardo CD, Ravandi F, Garcia-Manero G, Takahashi K, Konopleva M, Daver N, Issa GC, Andreeff M, Kantarjian H, Kadia TM. Short NJ, et al. Among authors: hwang h. Blood Adv. 2020 Nov 24;4(22):5681-5689. doi: 10.1182/bloodadvances.2020003120. Blood Adv. 2020. PMID: 33211826 Free PMC article.
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis.
Short NJ, Fu C, Berry DA, Walter RB, Freeman SD, Hourigan CS, Huang X, Gonzalez GN, Hwang H, Qi X, Kantarjian H, Zhou S, Ravandi F. Short NJ, et al. Among authors: hwang h. Leukemia. 2022 Dec;36(12):2817-2826. doi: 10.1038/s41375-022-01692-0. Epub 2022 Oct 19. Leukemia. 2022. PMID: 36261575
4,791 results